![1]()
News
SGLT2 inhibitor use rising in patients with DKD
August 23, 2021
Use of SGLT2 inhibitors in patients with type 2 diabetes rose sharply in 2019 and early 2020. GLP-1 RA use also showed recent gains.
![1]()
News
Apixaban more effective, safer than rivaroxaban for Afib patients
August 23, 2021
Is apixaban more effective and safer than rivaroxaban in patients with atrial fibrillation?
News
FDA fully approves Pfizer COVID-19 vaccine
August 23, 2021
It is the first COVID-19 vaccine to be fully licensed in the United States. It will be marketed under the trade name Comirnaty.
![1]()
News
Weathering this storm and the next
August 20, 2021
Disaster preparedness is achieved with the nonstop cycle of planning, coordinating, and recognizing vulnerable areas.
News
Tocilizumab shortage continues as pandemic wears on
August 19, 2021
Emergency use authorization of tocilizumab for COVID-19 has led to a global shortage, but supplies for rheumatoid arthritis and other inflammatory conditions are faring better – for now.
News
Empagliflozin gets HFrEF approval from FDA
August 19, 2021
The SGLT2 inhibitor empagliflozin (Jardiance) becomes the second agent from this class to get a heart failure indication regardless of diabetes status.
![1]()
Opinion
An ethics challenge in hospital medicine
August 19, 2021
It is important not to force a premature resolution of the situation through unilateral or coercive decisions.
News
COVID-19 booster shots to start in September: Officials
August 18, 2021
Booster shots to ramp up protection against COVID-19 infection are slated to begin the week of Sept. 20, the Biden administration announced at a press briefing August 18.Those who received the Pfizer-BioNTech and Moderna vaccines ...
News
Latest data show increase in breakthrough COVID-19 cases
August 18, 2021
“Remember when the early vaccine studies came out, it was like nobody gets hospitalized, nobody dies. ... That clearly is not true.”
![1]()
News
Mental health after ICU: It’s complicated
August 18, 2021
A prospective study in Brazil finds a range of factors that influence susceptibility to anxiety, depression, and PTSD following ICU stays.
